This grant offered by the National Institute of Allergy and Infectious Diseases aims to support research on the molecular mechanisms of immune activation and inflammation induced by HIV infection in the presence of antiretroviral therapy (ART) and drugs of abuse. The research seeks to provide insights for developing interventions to reduce chronic inflammation-related comorbidities and enhance ART efficacy in HIV-infected individuals with substance abuse disorders. Application deadline: November 18, 2016.
Opportunity ID: 286670
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-17-013 |
Funding Opportunity Title: | Mechanisms of Immune Activation and Inflammation: HIV Infection, ART, and Drugs of Abuse (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jul 28, 2016 |
Last Updated Date: | – |
Original Closing Date for Applications: | Nov 18, 2016 |
Current Closing Date for Applications: | Nov 18, 2016 |
Archive Date: | Dec 19, 2016 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | County governments City or township governments Independent school districts State governments For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this FOA is to promote research to investigate the underlying molecular mechanisms of HIV infection-induced immune activation and inflammation in the presence of antiretroviral therapy (ART) agents and drugs of abuse. The ultimate goal is to obtain information for developing therapeutic interventions for attenuating chronic inflammation-associated comorbidities as well as for restoring or improving ART efficacy in HIV-infected drug-abusing populations. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-17-013.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00226166 | Oct 18, 2016 | Nov 18, 2016 | View |
Package 1
Mandatory forms
286670 RR_SF424_2_0-2.0.pdf
286670 PHS398_CoverPageSupplement_3_0-3.0.pdf
286670 RR_OtherProjectInfo_1_3-1.3.pdf
286670 PerformanceSite_2_0-2.0.pdf
286670 RR_KeyPersonExpanded_2_0-2.0.pdf
286670 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
286670 RR_Budget_1_3-1.3.pdf
286670 RR_SubawardBudget30_1_3-1.3.pdf
286670 PHS398_ModularBudget_1_2-1.2.pdf
286670 PHS_Inclusion_Enrollment_Report-1.0.pdf
286670 PHS_AssignmentRequestForm-1.0.pdf